Changes for page Clinical trials

Summary

• Page properties (2 modified, 0 added, 0 removed)

Details

Page properties

Author

...	...	@@ -1,1 +1,1 @@
1		-XWiki.Sarantis
	1	+XWiki.XWikiGuest

Content

...	...	@@ -1,35 +1,21 @@
1		-(% class="western" lang="en-GB" style="text-align:justify" %)
2		-(% lang="en-US" style="line-height:107%" %)**Description: **Clinical trials are experiments or observations done to evaluate the effectiveness and safety of new solution by monitoring its effects on large groups of people. Subjects are typically divided into two or more groups, one having “real treatment” by using the developed solution and the other group(s) using tried-and-true solution or not using any solution. The results are compared between the groups to evaluate the impacts.
	1	+**Description: **Clinical trials are experiments or observations done to evaluate the effectiveness and safety of new solution by monitoring its effects on large groups of people. Subjects are typically divided into two or more groups, one having “real treatment” by using the developed solution and the other group(s) using tried-and-true solution or not using any solution. The results are compared between the groups to evaluate the impacts.
3	3
4		-(% class="western" lang="en-GB" style="text-align:justify" %)
5		-(% lang="en-US" style="line-height:107%" %)**R&D service category-ies: **Testing and validation
	3	+**R&D service categories: **Testing and validation
6	6
7		-(% class="western" lang="en-GB" style="text-align:justify" %)
8		-(% lang="en-US" style="line-height:107%" %)**Key characteristics in Living Lab context:**
	5	+**Key characteristics in living lab context:**
9	9
10		-* (((
11		-(% lang="en-GB" style="text-align:justify" %)
12		-(% lang="en-US" style="line-height:107%" %)Clinical trials are similar to impact assessment and validation test activities but follow more strict validation and approval process.
13		-)))
	7	+* Clinical trials are similar to impact assessment and validation test activities but follow more strict validation and approval process.
14	14
15		-(% class="western" lang="en-GB" style="text-align:justify" %)
16		-(% lang="en-US" style="line-height:107%" %)**Participants’ role:**
	9	+**Participants’ role:**
17	17
18		-* (((
19		-(% lang="en-GB" style="text-align:justify" %)
20		-(% lang="en-US" style="line-height:107%" %)Customers as co-creators
21		-)))
	11	+* Customers as co-creators
22	22
23		-(% class="western" lang="en-GB" style="text-align:justify" %)
24	24	**Objectives**
25	25
26		-* (% lang="en-US" style="line-height:107%" %)To find out if new solutions are safe and effective
27		-* (% lang="en-US" style="line-height:107%" %)Get official approval for new solution
	15	+* To find out if new solution is safe and effective
	16	+* Get official approval for new solution
28	28
29		-(% class="western" lang="en-GB" style="text-align:justify" %)
30		-(% lang="en-US" style="line-height:107%" %)**Methods:**
	18	+**Methods: **Has multiple phases and classes which depend on the developed solution
31	31
32		-* (((
33		-(% lang="en-GB" style="text-align:justify" %)
34		-(% lang="en-US" style="line-height:107%" %)Has multiple phases and classes which depend on the developed solution
35		-)))
	20	+
	21	+**Approved by** the VITALISE H2020 living labs' consensus report on 30/09/2021